---
category: listing
circular_id: ce804fea3d268d65
date: '2025-08-25'
description: BSE circular detailing the listing of new equity shares for Novelix Pharmaceuticals
  Limited with lock-in periods.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={E1C44796-15FD-4EA3-B52A-B965D224BBA7}&noticeno=20250825-20&dt=08/25/2025&icount=20&totcount=65&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of securities with standard lock-in periods affecting
  single company
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250825-20&attachedId=030efed6-309f-4f9c-8907-9aa2c0762108
processing:
  attempts: 1
  content_hash: e6bbfa06ef0ab120
  processed_at: '2025-08-25T15:36:03.643797'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-25T10:52:27+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={E1C44796-15FD-4EA3-B52A-B965D224BBA7}&noticeno=20250825-20&dt=08/25/2025&icount=20&totcount=65&flag=0
severity: low
source: bse
stocks:
- NOVELIX
tags:
- listing
- new-securities
- equity-shares
- lock-in
- novelix-pharmaceuticals
title: Listing of New Securities of NOVELIX PHARMACEUTICALS LIMITED
---

## Summary

BSE has listed new equity shares of Novelix Pharmaceuticals Limited. The circular provides details of 19 tranches of equity shares totaling 26,35,000 shares with distinctive numbers ranging from 9950001 to 12935000.

## Key Points

- Total of 26,35,000 new equity shares listed
- 19 separate tranches with varying quantities from 10,000 to 15,00,000 shares
- Distinctive numbers allocated from 9950001 to 12935000
- All shares subject to lock-in periods

## Regulatory Changes

No regulatory changes mentioned in this circular.

## Compliance Requirements

- Securities are subject to lock-in periods as specified
- Trading restrictions apply until lock-in end dates

## Important Dates

- Lock-in end dates vary:
  - Most tranches: March 30, 2026
  - Some tranches: March 31, 2026
  - One tranche: March 30, 2027

## Impact Assessment

Minimal market impact as this is a routine listing of new securities for a single company. The lock-in periods ensure gradual market availability of these shares.